SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-039417
Filing Date
2023-08-14
Accepted
2023-08-14 08:10:43
Documents
16
Period of Report
2023-08-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20057474_8k.htm   iXBRL 8-K 40664
2 EXHIBIT 99.1 brhc20057474_ex99-1.htm EX-99.1 13299
7 image00003.jpg GRAPHIC 2332
8 image00004.jpg GRAPHIC 1705
  Complete submission text file 0001140361-23-039417.txt   244765

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bngo-20230811.xsd EX-101.SCH 4327
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20230811_def.xml EX-101.DEF 17538
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20230811_lab.xml EX-101.LAB 27036
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20230811_pre.xml EX-101.PRE 19723
10 EXTRACTED XBRL INSTANCE DOCUMENT brhc20057474_8k_htm.xml XML 6220
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 231166441
SIC: 3826 Laboratory Analytical Instruments